Barbara Ingold Heppner

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy

Carsten Denkert, Gϋnter von Minckwitz, Silvia Darb‐Esfahani et al. · The Lancet Oncology · 2017 · 2.1K citations

Medicine, Immunology, Oncology +14

Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group

Carsten Denkert, Stephan Wienert, Audrey Poterie et al. · Modern Pathology · 2016 · 279 citations · Full text

Life Sciences, Immunology, Oncology +17

Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer

Barbara Ingold Heppner, Michael Untch, Carsten Denkert et al. · Clinical Cancer Research · 2016 · 202 citations

Medicine, Immunology, Oncology +16

HER2/neu testing in primary colorectal carcinoma

Barbara Ingold Heppner, HM Behrens, Katharina Balschun et al. · British Journal of Cancer · 2014 · 169 citations · Full text

Medicine, Oncology, Pathology +13

Olfactory transmucosal SARS-CoV-2 invasion as port of Central Nervous System entry in COVID-19 patients

Jenny Meinhardt, Josefine Radke, Carsten Dittmayer et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 137 citations · Full text

Veterinary Medicine, Infectious Diseases, Neuroscience +17